Home › Funds › MONTANOVA CAPITAL, LLC › CAPR
MONTANOVA CAPITAL, LLC position in CAPR
CAPRICOR THERAPEUTICS INC COM NEW · Health Care
MONTANOVA CAPITAL, LLC reported holding 4,092,784 shares of CAPR (CAPRICOR THERAPEUTICS INC COM NEW) in its Q2 2026 13F filing — a position valued at US$98.6M, representing 1.80% of its reported portfolio and ranking #19 among its reported holdings. MONTANOVA CAPITAL, LLC has disclosed CAPR holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How MONTANOVA CAPITAL, LLC's CAPR position evolved
MONTANOVA CAPITAL, LLC first disclosed a stake in CAPR in Q4 2025 at 1,785,610 shares (US$51.5M). The position peaked in Q1 2026 at 3,818,600 shares, worth US$116.1M. Across 3 filings, MONTANOVA CAPITAL, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 4,092,784 shares valued at US$98.6M — an increase of 274,184 shares quarter over quarter.. Notable position changes include a 114% increase in Q1 2026 (shares fell 21% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 1.79M | $51.53M | New |
| Q1 2026 | 3.82M | $116.09M | Add |
| Q2 2026 | 4.09M | $98.55M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CAPR and 13F data
CAPR (CAPRICOR THERAPEUTICS INC COM NEW) is a Health Care company. 64 other funds we track also report a position in CAPR — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$98.7M), RA CAPITAL MANAGEMENT, L.P. (US$36.3M), Boxer Capital Management, LLC (US$33.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CAPR
- TANG CAPITAL MANAGEMENT LLC 4.10M sh · $98.73M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.51M sh · $36.31M · Q2 2026
- Boxer Capital Management, LLC 1.40M sh · $33.60M · Q2 2026
- Soleus Capital Management, L.P. 761.74K sh · $18.34M · Q2 2026
- DG Capital Management, LLC 611.60K sh · $14.73M · Q2 2026
- Jones Hill Capital LP 420.75K sh · $10.13M · Q2 2026
- Ikarian Capital, LLC 350.00K sh · $8.43M · Q2 2026
- DIADEMA PARTNERS LP 329.30K sh · $7.93M · Q2 2026
- Palo Alto Investors LP 229.76K sh · $5.53M · Q2 2026
More on MONTANOVA CAPITAL, LLC
FAQ
How long has MONTANOVA CAPITAL, LLC held CAPR?
MONTANOVA CAPITAL, LLC has disclosed CAPR holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is MONTANOVA CAPITAL, LLC's current position in CAPR?
As of Q2 2026, MONTANOVA CAPITAL, LLC holds 4.09M shares of CAPR (CAPRICOR THERAPEUTICS INC COM NEW), valued at $98.55M, representing 1.80% of its reported portfolio and ranking #19.
Has MONTANOVA CAPITAL, LLC been buying or selling CAPR?
In the latest 13F filing (Q2 2026), MONTANOVA CAPITAL, LLC increased its position in CAPR. The position peaked in Q1 2026 at 3.82M shares.
Which other funds hold CAPR?
Other major institutional holders of CAPR include TANG CAPITAL MANAGEMENT LLC, RA CAPITAL MANAGEMENT, L.P., Boxer Capital Management, LLC, among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.